DRREDDYNSEDr. Reddy's Laboratories Limited· PharmaceuticalsLowNeutral
Announced Thu, 26 Mar · 14:33 IST

Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Allotment of Employee Stock Options'.

Capital Market Events View source PDF

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.3%1-day move
₹1307.90
prior close
₹1297.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6-0.7-0.4+0.1-4.3-7.7-7.2-7.0-8.4-7.5-6.9+2.1+0.9+5.5
Up moveDown movePending
AI summary

Dr. Reddy's Laboratories allotted 3,675 equity shares of Re. 1 each to eligible employees on March 26, 2026, pursuant to the exercise of stock options under the Dr. Reddy's Employees ADR Stock Option Scheme, 2007. Of these, 575 shares were issued at Re. 1 per share and 3,100 shares at Rs. 735.80 per share. Post-allotment, the total issued share capital stands at Rs. 83,46,57,970, comprising 83,46,57,970 equity shares. The newly issued shares rank equally with existing shares and carry no lock-in restrictions. This is a routine disclosure under SEBI's employee benefits regulations.

Likely market impact

This is a routine, non-material ESOP allotment with negligible dilution (3,675 shares out of over 83 crore). It is unlikely to have any meaningful impact on the share price or shareholder value.